OTC · Financial Statements
NuGen Medical Devices Inc. (NGMDF) Financial Statements
$0.02
OTC: NGMDF
Market Cap $3.55M
Overview Financials Dividend
NuGen Medical Devices Inc. most recently reported annual revenue of $0, a net loss of $8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $1.0M $0 Operating Profit $-8.0M $-5.0M $-8.0M $-5.0M $-4.0M Net Profit $-7.0M $-6.0M $-9.0M $-5.0M $-8.0M EPS $-0.10 $-0.06 $-0.06 $-0.02 $-0.03 Op Margin -5573.1% -3146.6% -2428.5% -510.7% -1636.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $9.0M $7.0M $7.0M $13.0M $4.0M Total Liabilities $7.0M $9.0M $9.0M $19.0M $18.0M Cash $2.0M $0 $0 $7.0M $3.0M Borrowings $6.0M $7.0M $8.0M $18.0M $17.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-4.0M $-2.0M $-7.0M $-5.0M $-4.0M Investing Cash Flow $0 $0 $0 $0 $-1.0M Financing Cash Flow $0 $0 $1.0M $1.0M $0 Net Cash Flow $1.0M $-2.0M $0 $6.0M $-3.0M Free Cash Flow $-4.0M $-2.0M $-7.0M $-5.0M $-4.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -4.85 FCF Yield -88.53% Quick Ratio 0.57 Interest Coverage -1.39 Return 1Y -58.16% Return 3Y -87.63% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .